• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

手术切除和剜除术治疗胰腺神经内分泌肿瘤患者的预后分析及应用

Prognosis analysis of patients with pancreatic neuroendocrine tumors after surgical resection and the application of enucleation.

机构信息

Department of Hepatobiliary Surgery, Nanfang Hospital, Southern Medical University, 1838 Guangzhou North Ave, Guangzhou, 510515, Guangdong Province, China.

出版信息

World J Surg Oncol. 2021 Jan 12;19(1):11. doi: 10.1186/s12957-020-02115-z.

DOI:10.1186/s12957-020-02115-z
PMID:33436017
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7805225/
Abstract

OBJECTIVE

To investigate the prognostic factors of patients with pancreatic neuroendocrine tumor (pNETs) after surgical resection, and to analyze the value of enucleation for pNETs without distant metastasis that are well-differentiated (G1) and have a diameter ≤ 4 cm.

METHODS

Data from pNET patients undergoing surgical resection between 2004 and 2017 were collected from the Surveillance, Epidemiology, and End Results (SEER) database. Kaplan-Meier analysis and log-rank testing were used for the survival comparisons. Adjusted HRs with 95% CIs were calculated using univariate and multivariate Cox regression models to estimate the prognostic factors. P < 0.05 was regarded as statistically significant.

RESULTS

This study found that female, cases diagnosed after 2010, and pancreatic body/tail tumors were protective factors for good survival, while histological grade G3, a larger tumor size, distant metastasis, AJCC 8th stage III-IV and age over 60 were independent prognostic factors for a worse OS/CSS. For the pNETs that were well-differentiated (G1) and had a tumor diameter ≤ 4 cm, the type of surgery was an independent factor for the long-term prognosis of this group. Compared with pancreaticoduodenectomy and total pancreatectomy, patients who were accepted enucleation had better OS/CSS.

CONCLUSION

For pNETs patients undergoing surgical resection, sex, year of diagnosis, tumor location, pathological grade, tumor size, distant metastasis, race, and age were independent prognostic factors associated with the OS/CSS of patients. For pNETs patients with G1 and a tumor diameter less than 4 cm, if the tumor was located over 3 mm from the pancreatic duct, enucleation may be a wise choice.

摘要

目的

探讨胰腺神经内分泌肿瘤(pNETs)患者手术后的预后因素,并分析对于无远处转移、分化良好(G1)且直径≤4cm 的 pNETs 行剜除术的价值。

方法

从 SEER 数据库中收集了 2004 年至 2017 年间接受手术切除的 pNET 患者的数据。采用 Kaplan-Meier 分析和对数秩检验进行生存比较。使用单因素和多因素 Cox 回归模型计算调整后的 HR 及其 95%CI,以评估预后因素。P<0.05 为统计学显著差异。

结果

本研究发现,女性、2010 年后诊断的病例以及胰腺体/尾部肿瘤是良好生存的保护因素,而组织学分级 G3、肿瘤较大、远处转移、AJCC 第 8 版分期 III-IV 期和年龄大于 60 岁是总生存/无进展生存期(CSS)较差的独立预后因素。对于分化良好(G1)且肿瘤直径≤4cm 的 pNETs,手术类型是该组患者长期预后的独立因素。与胰十二指肠切除术和全胰切除术相比,接受剜除术的患者具有更好的 OS/CSS。

结论

对于接受手术切除的 pNETs 患者,性别、诊断年份、肿瘤位置、病理分级、肿瘤大小、远处转移、种族和年龄是与 OS/CSS 相关的独立预后因素。对于 G1 且肿瘤直径小于 4cm 的 pNETs 患者,如果肿瘤距离胰管超过 3mm,剜除术可能是明智的选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25b2/7805225/3cfc0771302b/12957_2020_2115_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25b2/7805225/550e507d8c59/12957_2020_2115_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25b2/7805225/7b75746535d8/12957_2020_2115_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25b2/7805225/3cfc0771302b/12957_2020_2115_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25b2/7805225/550e507d8c59/12957_2020_2115_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25b2/7805225/7b75746535d8/12957_2020_2115_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25b2/7805225/3cfc0771302b/12957_2020_2115_Fig3_HTML.jpg

相似文献

1
Prognosis analysis of patients with pancreatic neuroendocrine tumors after surgical resection and the application of enucleation.手术切除和剜除术治疗胰腺神经内分泌肿瘤患者的预后分析及应用
World J Surg Oncol. 2021 Jan 12;19(1):11. doi: 10.1186/s12957-020-02115-z.
2
Surgical resection of primary tumor is associated with prolonged survival in low-grade pancreatic neuroendocrine tumors.手术切除原发肿瘤与低级别胰腺神经内分泌肿瘤患者的生存延长相关。
Clin Res Hepatol Gastroenterol. 2021 Jan;45(1):101432. doi: 10.1016/j.clinre.2020.04.003. Epub 2020 May 5.
3
Optimal surgical management of unifocal vs. multifocal NF-PNETs: a respective cohort study.单灶性与多灶性神经内分泌胰腺肿瘤的最佳手术管理:一项队列研究。
World J Surg Oncol. 2024 Apr 26;22(1):115. doi: 10.1186/s12957-024-03383-9.
4
Clinicopathological features and prognosis factors for survival in elderly patients with pancreatic neuroendocrine tumor: A STROBE-compliant article.老年胰腺神经内分泌肿瘤患者的临床病理特征及生存预后因素:一篇遵循STROBE规范的文章
Medicine (Baltimore). 2019 Mar;98(11):e14576. doi: 10.1097/MD.0000000000014576.
5
Impact of extent of surgery on survival in patients with small nonfunctional pancreatic neuroendocrine tumors in the United States.手术范围对美国小型无功能胰腺神经内分泌肿瘤患者生存的影响。
Ann Surg Oncol. 2014 Oct;21(11):3515-21. doi: 10.1245/s10434-014-3769-4. Epub 2014 May 20.
6
A Survival Analysis of Patients with Localized, Asymptomatic Pancreatic Neuroendocrine Tumors: No Surgical Survival Benefit when Examining Appropriately Selected Outcomes.局限性无症状胰腺神经内分泌肿瘤患者的生存分析:选择合适的结局指标进行检查时,手术并不能带来生存获益。
J Gastrointest Surg. 2020 Dec;24(12):2773-2779. doi: 10.1007/s11605-019-04433-4. Epub 2019 Nov 21.
7
Clinical outcome and long-term survival of 150 consecutive patients with pancreatic neuroendocrine tumors: A comprehensive analysis by the World Health Organization 2010 grading classification.150例连续性胰腺神经内分泌肿瘤患者的临床结局及长期生存情况:基于世界卫生组织2010年分级分类的综合分析
Clin Res Hepatol Gastroenterol. 2018 Jun;42(3):261-268. doi: 10.1016/j.clinre.2017.09.004. Epub 2018 Jan 5.
8
Clinical significance of the preoperative main pancreatic duct dilation and neutrophil-to-lymphocyte ratio in pancreatic neuroendocrine tumors (PNETs) of the head after curative resection.根治性切除术后胰头神经内分泌肿瘤(PNETs)术前主胰管扩张和中性粒细胞与淋巴细胞比值的临床意义。
BMC Endocr Disord. 2019 Nov 12;19(1):123. doi: 10.1186/s12902-019-0454-4.
9
Surgical resection of the primary tumor leads to prolonged survival in metastatic pancreatic neuroendocrine carcinoma.手术切除原发肿瘤可延长转移性胰腺神经内分泌肿瘤患者的生存时间。
World J Surg Oncol. 2019 Mar 21;17(1):54. doi: 10.1186/s12957-019-1597-5.
10
Population-level analysis of pancreatic neuroendocrine tumors 2 cm or less in size.分析胰腺神经内分泌肿瘤 2cm 或以下的人群水平。
Ann Surg Oncol. 2013 Sep;20(9):2815-21. doi: 10.1245/s10434-013-3005-7. Epub 2013 Jun 15.

引用本文的文献

1
Clinicopathologic risk factors for post-operative complications after enucleation of pancreatic neoplasms.胰腺肿瘤摘除术后术后并发症的临床病理危险因素
World J Surg Oncol. 2025 Jul 22;23(1):293. doi: 10.1186/s12957-025-03920-0.
2
Glucagonoma and Glucagonoma Syndrome: An Updated Review.胰高血糖素瘤与胰高血糖素瘤综合征:最新综述
Clin Endocrinol (Oxf). 2025 Oct;103(4):417-426. doi: 10.1111/cen.15300. Epub 2025 Jul 4.
3
Prognostic Nomograms for Patients With NF-Pan-NET After Pancreatectomy: A Retrospective Analysis Based on SEER Database.

本文引用的文献

1
Analysis of recurrence after resection of well-differentiated non-functioning pancreatic neuroendocrine tumors.高分化无功能性胰腺神经内分泌肿瘤切除术后复发情况分析
Medicine (Baltimore). 2020 Jun 12;99(24):e20324. doi: 10.1097/MD.0000000000020324.
2
Trends in the Number of Lymph Nodes Evaluated Among Patients with Pancreatic Neuroendocrine Tumors in the United States: A Multi-Institutional and National Database Analysis.美国胰腺神经内分泌肿瘤患者评估淋巴结数量的趋势:多机构和国家数据库分析。
Ann Surg Oncol. 2020 Apr;27(4):1203-1212. doi: 10.1245/s10434-019-08120-1. Epub 2019 Dec 14.
3
Surgical management of pancreatic neuroendocrine tumors: an introduction.
基于 SEER 数据库的胰腺切除术后 NF-Pan-NET 患者预后列线图:一项回顾性分析。
Cancer Rep (Hoboken). 2024 Sep;7(9):e2165. doi: 10.1002/cnr2.2165.
4
Comparative Analysis of Complications Following Distal Resections for Neuroendocrine Tumors and Adenocarcinoma: Unveiling the Differences.神经内分泌肿瘤和腺癌远端切除术后并发症的对比分析:揭示差异。
Med Sci Monit. 2024 Aug 19;30:e943307. doi: 10.12659/MSM.943307.
5
A novel model for predicting postoperative liver metastasis in R0 resected pancreatic neuroendocrine tumors: integrating computational pathology and deep learning-radiomics.一种用于预测 R0 切除胰腺神经内分泌肿瘤术后肝转移的新模型:整合计算病理学和深度学习-放射组学。
J Transl Med. 2024 Aug 14;22(1):768. doi: 10.1186/s12967-024-05449-4.
6
p21 Protein Outperforms Clinico-pathological Criteria in Predicting Liver Metastases in Pancreatic Endocrine Tumors.p21 蛋白在预测胰腺内分泌肿瘤肝转移方面优于临床病理标准。
Cancer Genomics Proteomics. 2023 Nov-Dec;20(6):522-530. doi: 10.21873/cgp.20402.
7
Management Dilemma: Is Enucleation With Lymphadenectomy a Viable Choice for Large Pancreatic Neuroendocrine Tumors (p-NETs)?管理困境:眼球摘除术联合淋巴结清扫术对大型胰腺神经内分泌肿瘤(p-NETs)来说是一个可行的选择吗?
Cureus. 2023 Jul 26;15(7):e42482. doi: 10.7759/cureus.42482. eCollection 2023 Jul.
8
A Machine Learning Approach Using [F]FDG PET-Based Radiomics for Prediction of Tumor Grade and Prognosis in Pancreatic Neuroendocrine Tumor.一种基于[F]FDG PET的放射组学的机器学习方法用于预测胰腺神经内分泌肿瘤的肿瘤分级和预后
Mol Imaging Biol. 2023 Oct;25(5):897-910. doi: 10.1007/s11307-023-01832-7. Epub 2023 Jul 3.
9
Two machine learning-based nomogram to predict risk and prognostic factors for liver metastasis from pancreatic neuroendocrine tumors: a multicenter study.两个基于机器学习的列线图模型,用于预测胰腺神经内分泌肿瘤肝转移的风险和预后因素:一项多中心研究。
BMC Cancer. 2023 Jun 9;23(1):529. doi: 10.1186/s12885-023-10893-4.
10
Machine learning-based model for prediction and feature analysis of recurrence in pancreatic neuroendocrine tumors G1/G2.基于机器学习的胰腺神经内分泌瘤 G1/G2 复发预测及特征分析模型
J Gastroenterol. 2023 Jun;58(6):586-597. doi: 10.1007/s00535-023-01987-8. Epub 2023 Apr 26.
胰腺神经内分泌肿瘤的外科治疗:引言。
Expert Rev Anticancer Ther. 2019 Dec;19(12):1089-1100. doi: 10.1080/14737140.2019.1703677. Epub 2019 Dec 17.
4
Prognostic and predictive factors on overall survival and surgical outcomes in pancreatic neuroendocrine tumors: recent advances and controversies.胰腺神经内分泌肿瘤的总生存和手术结局的预后和预测因素:最新进展和争议。
Expert Rev Anticancer Ther. 2019 Dec;19(12):1029-1050. doi: 10.1080/14737140.2019.1693893. Epub 2019 Nov 27.
5
The prognostic analysis of different metastatic patterns in pancreatic neuroendocrine tumors patients: A population based analysis.胰腺神经内分泌肿瘤患者不同转移模式的预后分析:一项基于人群的分析。
Medicine (Baltimore). 2019 Nov;98(44):e17773. doi: 10.1097/MD.0000000000017773.
6
Impact of tumor size and nodal status on recurrence of nonfunctional pancreatic neuroendocrine tumors ≤2 cm after curative resection: A multi-institutional study of 392 cases.肿瘤大小和淋巴结状态对功能性胰腺神经内分泌肿瘤≤2cm 根治性切除术后复发的影响:392 例多机构研究。
J Surg Oncol. 2019 Dec;120(7):1071-1079. doi: 10.1002/jso.25716. Epub 2019 Sep 30.
7
Leveraging machine learning techniques for predicting pancreatic neuroendocrine tumor grades using biochemical and tumor markers.利用机器学习技术,通过生化和肿瘤标志物预测胰腺神经内分泌肿瘤分级。
World J Clin Cases. 2019 Jul 6;7(13):1611-1622. doi: 10.12998/wjcc.v7.i13.1611.
8
Open and minimally invasive pancreatic neoplasms enucleation: a systematic review.开腹与微创胰腺肿瘤剜除术:系统综述。
Surg Endosc. 2019 Oct;33(10):3192-3199. doi: 10.1007/s00464-019-06967-9. Epub 2019 Jul 30.
9
Evaluation and Management of Neuroendocrine Tumors of the Pancreas.胰腺神经内分泌肿瘤的评估和管理。
Surg Clin North Am. 2019 Aug;99(4):793-814. doi: 10.1016/j.suc.2019.04.014. Epub 2019 May 27.
10
Ki-67 Index of 5% is Better Than 2% in Stratifying G1 and G2 of the World Health Organization Grading System in Pancreatic Neuroendocrine Tumors.Ki-67 指数为 5%优于 2%,可用于世界卫生组织分级系统中胰腺神经内分泌肿瘤 G1 和 G2 的分层。
Pancreas. 2019 Jul;48(6):795-798. doi: 10.1097/MPA.0000000000001331.